Arian Frasheri

Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy

Antonio Colombo, Alaide Chieffo, Arian Frasheri et al. · Journal of the American College of Cardiology · 2014 · 414 citations

Thrombosis, Endovascular Technique, Cardiovascular Disease +8

Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis

Remo Albiero, Sigmund Silber, Carlo Di Mario et al. · Journal of the American College of Cardiology · 2004 · 208 citations · Full text

Conventional Balloon Angioplasty, Endovascular Technique, Cardiovascular Disease +8

Small, dense low‐density lipoproteins (LDL) are predictors of cardio‐ and cerebro‐vascular events in subjects with the metabolic syndrome

Manfredi Rizzo, Vincenzo Pernice, Arian Frasheri et al. · Clinical Endocrinology · 2008 · 111 citations

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

Manfredi Rizzo, Vincenzo Pernice, Arian Frasheri et al. · Atherosclerosis · 2007 · 77 citations

Metabolic Syndrome, Cardiovascular Disease, Ldl Size +11

Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy

Giuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli et al. · International Journal of Cardiology · 2016 · 25 citations

Thrombosis, Diabetes Management, Dual Antiplatelet Therapy +9